Antipyretic TRIZ Cases

A Pediococcus acidilactici strain reduces weight loss and inflammation while restoring intestinal barriers.

Illumination devices excite nano-gold particles to break hydrogen bonds in water, forming stable small clusters without boiling.

Organic acids stabilize leflunomide by suppressing teriflunomide degradation during storage.

Steaming and defatting remove volatile essential oils from thyme, resolving stability issues while maintaining anti-inflammatory efficacy.

Sucrose and sorbitol prevent protein aggregation, maintaining bioactivity during long-term storage.

A cannabis-derived fraction containing at least 80% CBD, CBG, and THCV activates macrophages to modulate immune responses.

A plant extract composition attracts mesenchymal stem cells through chemotaxis to specific tissues.

Dissolves Crisaborole in propylene glycol to resolve chemical and physical stability issues in topical formulations for inflammatory skin conditions.

Bifidobacterium animalis subsp. lactis reduces abdominal pain in postmenopausal women.

Developing multiple crystalline polymorphs of the PARP14 inhibitor resolves formulation complexity while improving storage stability and bioavailability.

Pharmacokinetic modeling optimizes anifrolumab subcutaneous dosing to maintain efficacy while improving patient convenience over intravenous infusion.

A transmucosal film delivers dopamine agonists through the mucosal barrier.

Removing cell membranes from adipose-derived stem cells eliminates proliferation risks while maintaining hair regeneration and pain alleviation effects.

Extruded disc-shaped kibbles incorporating curcumin deliver therapeutic anti-inflammatory benefits while maintaining nutritional value.

Anti-IL1R3 antibodies target the IL-1 receptor accessory protein to inhibit multiple cytokine pathways, reducing treatment frequency and side effects.

Urine-derived exosomes isolate distinct miRNA profiles to diagnose interstitial pulmonary fibrosis before histological changes appear.

Free immunoglobulin light chains act as therapeutic agents to mitigate cardiac muscle lesions.

Branched-chain keto acids inhibit IL-6 and TNF-alpha secretion to resolve the trade-off between muscle protection and oxidative stress.

Nitric oxide generation from nitrite and acidic hydrogel enhances skin permeability for effective pain relief.

Specific amino acid substitutions in a humanized CD28 antibody reduce immunogenicity without compromising antigen-binding specificity for T cell regulation.

A soybean seed extract composition containing a vapor fraction alleviates cancer pain and treats skin inflammation.

Specific peptide sequences reduce inflammatory marker expression by targeting underlying mechanisms in chronic conditions.

An anti-Dectin-1 antibody conjugated to a TLR agonist targets antigen-presenting cells to modulate immune responses.

Deuterated acetaminophen substitutes hydrogen with deuterium, reducing toxic NAPQI metabolite formation and liver injury risk.

Hydroxylated fatty acids suppress nitric oxide production by M1 macrophages to resolve chronic inflammation.

Preconditioning with exogenous stem cells reduces ischemic reperfusion injury and inflammation, enhancing organ viability.

Segmenting IL-17 into distinct isoforms enables targeted antagonists that reduce cancer cell proliferation and chronic inflammation.

Low-dose cytotoxic anti-LAG-3 antibodies selectively deplete activated T cells through CDC and ADCC, avoiding non-selective immunosuppression side effects.

IL-1β binding antibodies inhibit inflammatory pathways to reduce plaque burden in peripheral arteries.

Mutated feline IgG variants increase neonatal Fc receptor binding affinity to extend serum circulation duration.

Combining hoki roe with green-lipped mussel powder resolves unreliable omega-3 content consistency while achieving enhanced anti-inflammatory efficacy.

Topical hypochlorous acid formulation modulates immune responses to restore skin barrier integrity, reducing inflammation without corticosteroid side effects.

A fatty acid synthase inhibitor compound reduces cellular lipid synthesis to arrest tumor cell growth.

Sodium butyrate combined with palmitoylethanolamide restores intestinal barrier integrity through synergistic modulation of tight junction proteins.

ABX464 alters viral RNA splicing patterns to upregulate anti-inflammatory miR-124 levels.

Glycopyrronium bromide lactose co-crystals address limited bioavailability by improving solubility and stability via specific stoichiometric ratios.

Sodium meta-arsenite reduces tumor size while minimizing toxicity to healthy tissues.

Segmented hydrogel and PLGA microspheres provide sustained atorvastatin release, resolving stability-biodegradability trade-offs to inhibit intimal hyperplasia.

Galectin-9 binding antibodies disrupt immunosuppressive PD-L2 interactions to increase TNF-alpha and IFN-gamma secretion.

Targeted 6-thioguanine release in the distal intestine leverages local bacterial conversion to minimize systemic hepatotoxicity and immunosuppression.

Prosopis glandulosa seed pod extract accelerates muscle tissue regeneration by reducing neutrophil infiltration and enhancing ADAM 12 expression.

Basic amino acid salts lower viscosity and prevent aggregation in high concentration antibody formulations for subcutaneous administration.

MPC5B4 antibody blocks periostin-integrin interaction to treat lung fibrosis without systemic immunosuppression side effects.

Synergistic combination reduces S1P modulator doses, lowering bradyarrhythmia and lymphopenia risks while maintaining anti-inflammatory efficacy.

Afucosylated antibody formulation prevents aggregation and fragmentation while preserving enhanced ADCC activity.

NADPH oxidase inhibitors lower reactive oxygen species to prevent surgery-induced inflammation and metastasis.